No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Benzamides
-
Hematologic Neoplasms / drug therapy*
-
Humans
-
Imatinib Mesylate
-
Piperazines / therapeutic use*
-
Practice Guidelines as Topic*
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Pyrimidines / therapeutic use*
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate
-
Protein-Tyrosine Kinases